About us

Our history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today, Akoya’s portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.

About us

Our history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today, Akoya’s portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research applications.

Explore our history
Akoya Biosciences Acquires Phenoptics

Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer to establish a combined portfolio of complementary technologies.

PerkinElmer Acquires Caliper Life Sciences

The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.

Cambridge Research & Instrumentation (CRI)

CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis.

The Spatial Biology Company™

Combining the strengths of CODEX and Phenoptics to accelerate tissue biomarker development, from discovery to translation.

Akoya Biosciences is Founded

Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.

Explore our history

TODAY
The Spatial Biology Company™

Combining the strengths of CODEX and Phenoptics to accelerate tissue biomarker development, from discovery to translation.

2018
Akoya Biosciences Acquires Phenoptics

Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer to establish a combined portfolio of complementary technologies.

2015
Akoya Biosciences is Founded

Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.

2011
PerkinElmer Acquires Caliper Life Sciences

The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.

1985
Cambridge Research & Instrumentation (CRI)

CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis.

Brian McKelligon

CEO

Akoya Biosciences

Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the Phenoptics and CODEX portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.

Akoya is excited to bring unprecedented power, scale, and automation to histology and single-cell analysis through our multiplex immunofluorescence solutions. With both the Phenoptics and CODEX portfolios, we provide our customers with a full suite of end-to-end solutions for high parameter tissue analysis.

Brian McKelligon

CEO

Akoya Biosciences